Role of Prostatic Fibrosis in BPH/LUTS Development & Symptomology
前列腺纤维化在 BPH/LUTS 发展中的作用
基本信息
- 批准号:8049846
- 负责人:
- 金额:$ 29.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAffectAgingAmericanAndrogensArchitectureAreaCellsClinicalDevelopmentEngineeringExhibitsExtracellular MatrixFacultyFeasibility StudiesFibrosisFunctional disorderGenitourinary systemHumanLaboratoriesMeasuresMechanicsMedicalMedicineMichiganMusMuscle RigidityMyofibroblastObesityObstructionPathologyPatientsProstateProstaticProstatic DiseasesProteinsRoleSchoolsSmooth MuscleTestingTherapeuticTissuesTransgenic MiceUniversitiesUrethraUrologic Diseasesbasedesignflexibilityin vitro testingin vivolower urinary tract symptomsmenmultidisciplinarynovel strategiespublic health relevancesenescencesoft tissuetherapeutic targeturinary
项目摘要
DESCRIPTION (provided by applicant): The proposed planning Center brings together a multidisciplinary team to explore a new paradigm that incorporates fibrosis as a contributing factor to urinary dysfunction and lower urinary tract symptoms (LUTS) development and progression. This team comprises faculty from two schools within the University of Michigan - Medicine and Engineering - that provides broad expertise in laboratory-based studies of urologic disease (Macoska), clinical expertise in treating prostate disease (Hollingsworth) and genitourinary pathology (Kunju), and in soft tissue mechanics (Arruda). The Center team has designed feasibility studies that employ quantitative approaches designed to measure fibrotic changes in human and mouse tissues and cells and to assess whether these fibrotic changes alter tissue rigidity/stiffness and thereby contribute to urinary dysfunction. These studies will test the specific hypothesis that extracellular matrix (ECM) remodeling by accumulating myofibroblasts in the aging prostate effectively generates a fibrotic prostate tissue architecture that increases tissue rigidity and reduces urethral flexibility, resulting in urinary flow obstruction and LUTS. These studies are organized into three Specific Aims:
Specific Aim 1 will determine whether tissues from the peri-urethral area of the human prostate in aging men and particularity those with LUTS demonstrate changes in the extracellular matrix (ECM) consistent with fibrosis, and whether these changes are associated with increased tissue ' mechanical rigidity and stiffness.
Specific Aim 2 will elucidate which proteins secreted by aging prostate stroma contribute to myofibroblast differentiation and ECM dysfunction in vitro, and test therapeutic approaches to inhibit or reverse these changes.
Specific Aim 3 will determine whether Senescence-Accelerated Mouse Prone 6 (SAMP6) and/or KC Transgenic mice exhibit changes in the ECM consistent with fibrosis, whether these changes are associated with increased tissue mechanical rigidity and stiffness, whether these changes affect urinary flow, and whether this pathology is exacerbated by obesity in vivo.
If successful, the results of these studies will open the door to a new approach to effectively treat LUTS especially among men who cannot tolerate or fail to respond to current medical therapeutic approaches.
PUBLIC HEALTH RELEVANCE: Lower urinary tract symptoms (LUTS) are a costly and critically progressive medical problem for millions of aging American men. Current therapeutic approaches for LUTS are focused on the ablation of androgen or smooth muscle activity, but these are not effective for all patients. This application seeks to determine whether a new class of therapeutics targeting tissue fibrosis may be developed to treat LUTS.
描述(由申请人提供):拟建的规划中心汇集了一个多学科团队,探索将纤维化作为泌尿功能障碍和下尿路症状(LUTS)发展和进展的促进因素的新范式。该团队由密歇根大学医学院和工程系两所学院的教师组成,他们在泌尿系统疾病(Macoska)的实验室研究、前列腺疾病(Hollingsworth)和泌尿生殖系统病理学(Kunju)的临床研究以及软组织力学(Arruda)方面提供广泛的专业知识。该中心团队设计了可行性研究,采用定量方法来测量人类和小鼠组织和细胞的纤维化变化,并评估这些纤维化变化是否会改变组织硬度/僵硬度,从而导致尿功能障碍。这些研究将验证细胞外基质(ECM)重构通过积累肌成纤维细胞在老化的前列腺有效地产生纤维化的前列腺组织结构,增加组织刚性和降低尿道灵活性,导致尿流阻塞和LUTS的具体假设。这些研究分为三个具体目标:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jill A. Macoska其他文献
Fluorescence In Situ Hybridization (FISH) to Metaphase and Interphase Chromosomes.
中期和间期染色体荧光原位杂交 (FISH)。
- DOI:
10.1385/1-59259-144-2:101 - 发表时间:
2001 - 期刊:
- 影响因子:0
- 作者:
Jill A. Macoska - 通讯作者:
Jill A. Macoska
Jill A. Macoska的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jill A. Macoska', 18)}}的其他基金
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction
IL-4/IL-13 自分泌环的持续存在促进纤维化介导的尿排尿功能障碍
- 批准号:
10022319 - 财政年份:2014
- 资助金额:
$ 29.84万 - 项目类别:
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction
IL-4/IL-13 自分泌环的持续存在促进纤维化介导的尿排尿功能障碍
- 批准号:
10700930 - 财政年份:2014
- 资助金额:
$ 29.84万 - 项目类别:
Persistence of an IL-4/IL-13 autocrine loop promotes fibrosis-mediated urinary voiding dysfunction
IL-4/IL-13 自分泌环的持续存在促进纤维化介导的尿排尿功能障碍
- 批准号:
10264807 - 财政年份:2014
- 资助金额:
$ 29.84万 - 项目类别:
Fibrosis-Associated Urinary Gene Transcripts for LUTS Detection and Treatment
用于 LUTS 检测和治疗的纤维化相关尿液基因转录
- 批准号:
8738645 - 财政年份:2013
- 资助金额:
$ 29.84万 - 项目类别:
Fibrosis-Associated Urinary Gene Transcripts for LUTS Detection and Treatment
用于 LUTS 检测和治疗的纤维化相关尿液基因转录
- 批准号:
8486921 - 财政年份:2013
- 资助金额:
$ 29.84万 - 项目类别:
Society for Basic Urologic Research Fall Symposium 2012
基础泌尿学研究学会 2012 年秋季研讨会
- 批准号:
8453755 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Role of Prostatic Fibrosis in BPH/LUTS Development & Symptomology
前列腺纤维化在 BPH/LUTS 发展中的作用
- 批准号:
8150959 - 财政年份:2010
- 资助金额:
$ 29.84万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 29.84万 - 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
- 批准号:
400097 - 财政年份:2019
- 资助金额:
$ 29.84万 - 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
- 批准号:
19K09017 - 财政年份:2019
- 资助金额:
$ 29.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
- 批准号:
18K09531 - 财政年份:2018
- 资助金额:
$ 29.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
- 批准号:
9766994 - 财政年份:2018
- 资助金额:
$ 29.84万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 29.84万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 29.84万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 29.84万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9925164 - 财政年份:2016
- 资助金额:
$ 29.84万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9345997 - 财政年份:2016
- 资助金额:
$ 29.84万 - 项目类别: